Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 19, 2019
Data on the Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System were not included in the meta-analyses that were catalysts for the panel meeting.
-
Jun 11, 2019
Vertiflex acquisition adds the only FDA-approved, commercially available, minimally invasive interspinous spacer to Boston Scientific’s chronic pain portfolio.
-
May 22, 2019Findings could expand number of patients who can receive alternative treatment to life-long use of blood thinners
WATCHMAN device findings could expand number of non-valvular atrial fibrillation (AFib) patients who can receive alternative treatment to lifelong use of blood thinners.
-
May 15, 2019
Boston Scientific (BSX) will participate in an upcoming investor conference in May 2019. A live webcast and replay will be available.
-
May 10, 2019New data further support use of S-ICD System as first-line therapy for majority of ICD patients
New clinical trial data further support use of Boston Scientific’s EMBLEM S-ICD System as first-line therapy for majority of ICD patients.